315 Martin Luther King Jr Way, 
Tacoma, WA 

Overview

Robert Irwin is a Pediatrics provider in Tacoma, Washington. His top areas of expertise are Classical Hodgkin Lymphoma, Hepatoblastoma, Gliomatosis Cerebri, Embryonal Tumor with Multilayered Rosettes, and Bone Marrow Aspiration. Dr. Irwin is currently accepting new patients.

His clinical research consists of co-authoring 1 peer reviewed article and participating in 42 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties
Pediatrics
Licenses
Pediatrics in WA
Languages Spoken
English
Hindi
Portuguese
Romanian
Spanish
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Cambia Health Solutions
  • EPO
  • INSURANCE PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Community Health
  • EPO
  • HMO
Coordinated Care
  • HMO
  • MANAGED MEDICAID PLAN
Group Health Cooperative
  • HMO
  • POS
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Medicare
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE PART D
PacificSource
  • PPO
Premera
  • EPO
  • PPO
Premera Blue Cross
  • INSURANCE PLAN
  • MEDICARE MAPD
  • OTHER COMMERCIAL
  • PPO
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
View 8 Less Insurance Carriers -

Locations

315 Martin Luther King Jr Way, Tacoma, WA 98405

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.


42 Clinical Trials

A Phase III Randomized Trial Investigating Bortezomib (NSC# 681239) on a Modified Augmented BFM (ABFM) Backbone in Newly Diagnosed T-Lymphoblastic Leukemia (T-ALL) and T-Lymphoblastic Lymphoma (T-LLy)
Randomized Phase 3 Trial Evaluating the Addition of the IGF-1R Monoclonal Antibody Ganitumab (AMG 479, NSC# 750008) to Multiagent Chemotherapy for Patients With Newly Diagnosed Metastatic Ewing Sarcoma
A Randomized Phase 3 Study of Brentuximab Vedotin (SGN-35) for Newly Diagnosed High-Risk Classical Hodgkin Lymphoma (cHL) in Children and Young Adults
A Phase III Randomized Trial for Newly Diagnosed High Risk B-Lymphoblastic Leukemia (B-ALL) Including a Stratum Evaluating Dasatinib (NSC#732517) in Patients With Ph-like Tyrosine Kinase Inhibitor (TKI) Sensitive Mutations
Treatment of Children With All Stages of Hepatoblastoma With Temsirolimus (NSC#683864) Added to High Risk Stratum Treatment
NCI-COG Pediatric MATCH (Molecular Analysis for Therapy Choice) Screening Protocol
A Randomized Phase 3 Trial of Nivolumab (NSC# 748726) in Combination With Chemo-Immunotherapy for the Treatment of Newly Diagnosed Primary Mediastinal B-Cell Lymphoma
A Phase 3 Trial Investigating Blinatumomab (NSC# 765986) in Combination With Chemotherapy in Patients With Newly Diagnosed Standard Risk or Down Syndrome B-Lymphoblastic Leukemia (B-ALL) and the Treatment of Patients With Localized B-Lymphoblastic Lymphoma (B-LLy)
Neuroblastoma Biology Studies
Phase III Randomized Trial of Post-Radiation Chemotherapy in Patients With Newly Diagnosed Ependymoma Ages 1 to 21 Years
International Phase 3 Trial in Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia (Ph+ALL) Testing Imatinib in Combination With Two Different Cytotoxic Chemotherapy Backbones
A Phase 2 Randomized Study of Irinotecan/Temozolomide/Dinutuximab With or Without Eflornithine (DFMO) in Children With Relapsed, Refractory or Progressive Neuroblastoma
Pediatric Hepatic Malignancy International Therapeutic Trial (PHITT)
A Phase 2 Study of Reduced Therapy for Newly Diagnosed Average-Risk WNT-Driven Medulloblastoma Patients
Utilizing Response- and Biology-Based Risk Factors to Guide Therapy in Patients With Non-High-Risk Neuroblastoma
Risk-Stratified Therapy for Acute Myeloid Leukemia in Down Syndrome
Treatment of Patients With Newly Diagnosed Standard Risk B-Lymphoblastic Leukemia (B-ALL) or Localized B-Lineage Lymphoblastic Lymphoma (B-LLy)
Renal Tumors Classification, Biology, and Banking Study
A Phase III Study for Patients With Newly Diagnosed Acute Promyelocytic Leukemia (APL) Using Arsenic Trioxide and All-Trans Retinoic Acid
View 41 Less Clinical Trials

1 Total Publications

Similar Doctors
Expertise in
12
conditions
Pediatrics
Expertise in
12
conditions
Pediatrics

Office

1900 9th Ave, 
Seattle, WA 
 (25.3 miles away)
Languages Spoken:
English
Offers Telehealth

Hans Ochs is a Pediatrics provider in Seattle, Washington. Dr. Ochs is highly rated in 12 conditions, according to our data. His top areas of expertise are Wiskott-Aldrich Syndrome, Primary Immunodeficiency (PID), X-Linked Agammaglobulinemia, and Immunodeficiency with Hyper IgM Type 1.

Expertise in
19
conditions
Medical Genetics | Pediatrics
Expertise in
19
conditions
Medical Genetics | Pediatrics
4800 Sand Point Way Ne # Oc.9850, 
Seattle, WA 
 (29.0 miles away)
Languages Spoken:
English, Arabic, Filipino, German, Spanish
Accepting New Patients
Offers Telehealth

Ghayda Mirzaa is a Medical Genetics specialist and a Pediatrics provider in Seattle, Washington. Dr. Mirzaa is highly rated in 19 conditions, according to our data. Her top areas of expertise are Increased Head Circumference, Cortical Dysplasia, Achalasia Microcephaly Syndrome, and Microcephaly. Dr. Mirzaa is currently accepting new patients.

Expertise in
8
conditions
Pediatrics | Neurology
Expertise in
8
conditions
Pediatrics | Neurology
315 Martin Luther King Jr Way, 
Tacoma, WA 
 (0.1 miles away)
Languages Spoken:
English, French, Hindi, Igbo, Japanese, Mandarin, Russian, Spanish, Swedish, Urdu, Vietnamese
Accepting New Patients
Offers Telehealth

Steven Phillips is a Pediatrics specialist and a Neurologist in Tacoma, Washington. Dr. Phillips is highly rated in 8 conditions, according to our data. His top areas of expertise are Generalized Tonic-Clonic Seizure, Seizures, Dravet Syndrome, and Myoclonic Epilepsy. Dr. Phillips is currently accepting new patients.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Irwin's expertise for a condition
ConditionClose
        View All 7 Experienced Conditions
        Want to save this doctor for later?
        Sign Up
        Is this your doctor?
        Find A Second Opinion
        Not sure about your diagnosis?
        Check Your Symptoms
         
         
         
         
        Learn about our expert tiers
        Learn More
        Are you the provider on this profile?
        Claim Profile